This was posted on another site: "This week's Feature profiles Melbourne, Australia-based Agenix (ASX:AGX; NASDAQ:AGXLY) and its ThromboView monoclonal antibody that detects live blood clots anywhere in the body. As CEO Nicholas Weston tells Leonard Zehr, the company is in partnering talks for ThromboView as it readies the product for Phase 3 clinical trials."
http://biotuesdays.com/2012/08/07/agenix-readies-thromboview-for-late-stage-clinical-trials/
- Forums
- ASX - By Stock
- CT1
- biotuesdays (usa) feature article on agenix
CT1
constellation technologies limited
Add to My Watchlist
0.00%
!
0.2¢

biotuesdays (usa) feature article on agenix
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
0.2¢ |
Change
0.000(0.00%) |
Mkt cap ! $2.949M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
39 | 34636742 | 0.1¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
0.2¢ | 7696726 | 8 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
38 | 34035991 | 0.001 |
0 | 0 | 0.000 |
0 | 0 | 0.000 |
0 | 0 | 0.000 |
0 | 0 | 0.000 |
Price($) | Vol. | No. |
---|---|---|
0.002 | 7696726 | 8 |
0.003 | 6779624 | 8 |
0.004 | 1004750 | 1 |
0.005 | 200000 | 1 |
0.006 | 127500 | 1 |
Last trade - 16.21pm 30/07/2025 (20 minute delay) ? |
Featured News
CT1 (ASX) Chart |